cancers Article Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog—GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition Elisabeth Peer 1, Sophie Karoline Aichberger 1, Filip Vilotic 1, Wolfgang Gruber 1,†, Thomas Parigger 1,2, Sandra Grund-Gröschke 1,‡, Dominik Patrick Elmer 1 , Florian Rathje 1, Andrea Ramspacher 1,3 , Mirko Zaja 4, Susanne Michel 4, Svetlana Hamm 4 and Fritz Aberger 1,* 1 Department of Bioscience, Cancer Cluster Salzburg, Paris-Lodron University Salzburg, 5020 Salzburg, Austria;
[email protected] (E.P.);
[email protected] (S.K.A.); viloticfi@web.de (F.V.); gruber.wolfi@gmail.com (W.G.);
[email protected] (T.P.);
[email protected] (S.G.-G.);
[email protected] (D.P.E.); fl
[email protected] (F.R.);
[email protected] (A.R.) 2 Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg Cancer Research Institute, Cancer Cluster Salzburg, IIIrd Medical Department, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria 3 Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria 4 4SC AG, Planegg-Martinsried, 82152 Planegg, Germany;
[email protected] (M.Z.);
[email protected] (S.M.);
[email protected] (S.H.) Citation: Peer, E.; Aichberger, S.K.; * Correspondence:
[email protected]; Tel.: +43-662-8044-5792 Vilotic, F.; Gruber, W.; Parigger, T.; † Present address: EVER Pharma GmbH, 4866 Unterach, Austria. Grund-Gröschke, S.; Elmer, D.P.; ‡ Present address: Immatics Biotechnologies GmbH, 72076 Tübingen, Germany.